Evidence map›Paper›PMID 35379254›Full record

ArticleOrphanet journal of rare diseases2022

Clinical and molecular analysis of four unrelated Chinese families with pathogenic KLHL40 variants causing nemaline myopathy 8.

Haiming Yuan, Qingming Wang, Xiumei Zeng, Peiqing He, Wanfang Xu, Hongmei Guo, Yanhui Liu, Yangyang Lin

Open access · goldAbstract readCase Reports
In one paragraph

Article in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. A Novel Splice Site Variant inMolecular syndromology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Haiming Yuan *Affiliated Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan, 523120, China.
Qingming Wang *Affiliated Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan, 523120, China.
Xiumei ZengAffiliated Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan, 523120, China.
Peiqing HeAffiliated Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan, 523120, China.
Wanfang XuAffiliated Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan, 523120, China.
Hongmei GuoAffiliated Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan, 523120, China.
Yanhui LiuAffiliated Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan, 523120, China. yh523120@sina.com.
Yangyang LinAffiliated Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan, 523120, China. Doctoral523120@sina.com.ORCID 0000-0002-3350-4972
Dongguan People’s Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHomozygous or compound heterozygous variants in the KLHL40 gene cause nemaline myopathy 8 (NEM8), a severe autosomal recessive muscle disorder characterized by prenatal polyhydramnios, fetal akinesia or hypokinesia, joint contractures, fractures, respiratory failure and dysphagia. Currently, 46 individuals with NEM8 have been described in the literature, and 30 variants in KLHL40 have been identified.

resultsHere, we reported five individuals from four unrelated Chinese families who presented common features of nemaline myopathy and infrequent clinical characteristics. Whole-exome sequencing (WES) was used to identify the causative gene. WES identified a recurrent missense variant c.1516A>C (p.Thr506Pro) and a novel frameshift variant c.543del (p.Ser182Profs*17) in KLHL40 in patient 1, a nonsense variant c.602G>A (p.Trp201*) and a missense variant c.1516A>C (p.Thr506Pro) in KLHL40 in patient 2, and homozygous variant c.1516A>C (p.Thr506Pro) in KLHL40 in patient 3 and both siblings (patients 4 and 5), all of which were confirmed by Sanger sequencing. Next, we estimated the incidence of this disorder in the southern and northern Chinese population to be 4.59/10

conclusionThe results of our study expand the mutation spectrum of KLHL40 and enrich our understanding of the clinical characteristics of NEM8. Genetic counseling was provided for the four families involved in this study. Given the severity and the relatively high incidence of this condition, we strongly suggest that KLHL40 be incorporated into a carrier screening panel for the Chinese population.

Indexed as

Myopathies, NemalineAsian PeopleChinaFemaleHomozygoteHumansMuscle ProteinsMutationPregnancyKLHL40 protein, humanMuscle ProteinsCarrier screeningFetal akinesiaKLHL40Nemaline myopathyPolyhydramniosRespiratory failure

Identifiers

PMID35379254
PMCPMC8981653
OpenAlexW4225597974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.